The B2B research program established a cohort newly diagnosed breast cancer cases with the objective of studying how breast cancer metastasizes to the bone. This cohort study has involved several sub-projects including one currently led by Dr. Kopciuk to investigate the impact of vitamin D and markers of inflammation in breast cancer metastases. Other projects are examining the detection of metabolomic profiles indicative of bone metastases or metastatic potential and the contribution of breast cancer stem cells to metastatic bone disease.
Co-Principal Investigators: Dr. Carrie Shemanko
Co-investigators: Dr. Nigel Brockton (currently at the American Institute of Cancer Research), Dr. Christine Friedenreich, Dr. Anthony Magliocco, Dr. Linda Cook, Dr. David Hanley
Funder: Alberta Cancer Foundation